Unusual clinical case: Pharmabortion in a patient with a donor kidney

Sergey P. Sinchikhin , Olga E. Nagaeva , Ekaterina S. Sinchikhina , Margarita D. Mustafaeva

V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2023, Vol. 10 ›› Issue (4) : 325 -331.

PDF
V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2023, Vol. 10 ›› Issue (4) : 325 -331. DOI: 10.17816/2313-8726-2023-10-4-325-331
Clinical case reports
research-article

Unusual clinical case: Pharmabortion in a patient with a donor kidney

Author information +
History +
PDF

Abstract

The study presents an algorithm for drug-induced abortion and prevention of complications after the procedure, with a clinical efficacy rate of 99.7%. In addition, a unique case is presented, involving the use of drugs to terminate a short-term pregnancy in a patient with chronic glomerulonephritis that affecting her kidney and chronic pyelonephritis in a previously transplanted second kidney. Given the lack of urinary organ dysfunction and the absence of clinical worsening of any somatic pathology at present, the medical consilium has determined that pharmabortion is permissible under dynamic monitoring of the patient. A single oral dose of 600 mg of mifepristone, followed by twice-daily administration of 400 mcg of misoprostol (per os) 36 h later, effectively terminated the unwanted pregnancy without adverse effects on extragenital diseases. Administering the gestagenic drug during the second phase of the menstrual cycle after abortion prevented ovarian dysfunction and endometrial hyperplasia.

Keywords

chronic pyelonephritis / chronic glomerulonephritis / kidney transplantation / medical abortion / mifepristone / misoprostol

Cite this article

Download citation ▾
Sergey P. Sinchikhin, Olga E. Nagaeva, Ekaterina S. Sinchikhina, Margarita D. Mustafaeva. Unusual clinical case: Pharmabortion in a patient with a donor kidney. V.F.Snegirev Archives of Obstetrics and Gynecology, 2023, 10(4): 325-331 DOI:10.17816/2313-8726-2023-10-4-325-331

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Serov VN, Sukhikh GT, Prilepskaya VN, Radzinskii VE, editors. Guidelines for outpatient care in obstetrics and gynecology. Moscow: GEOTAR-Media; 2016. 1136 p. (In Russ).

[2]

Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии / под ред. В.Н. Серова, Г.Т. Сухих, В.Н. Прилепской, В.Е. Радзинского. Москва : ГЭОТАР-Медиа, 2016. 1136 с.

[3]

Sinchikhin SP. Algorithm for medical abortion and post-abortion rehabilitation. Reproductive health of children and adolescents. 2008;(2):43–50. (In Russ).

[4]

Синчихин С.П. Алгоритм медикаментозного прерывания беременности и постабортной реабилитации // Репродуктивное здоровье детей и подростков. 2008. № 2. С. 43–50.

[5]

Sukhikh GT, Serov VN, Prilepskaya VN, et al. Medical termination of pregnancy. Clinical Guidelines (treatment protocol). Moscow: Ministry of Health of Russia; 2015. (In Russ).

[6]

Сухих Г.Т., Серов В.Н., Прилепская В.Н., и др. Медикаментозное прерывание беременности. Клинические реко- мендации (протокол лечения). Москва : Минздрав России, 2015.

[7]

Dikke GB. Medical abortion. A guide for doctors / Radzinskii VE, ed. Moscow: MEDpress-inform; 2015. (In Russ).

[8]

Дикке Г.Б. Медикаментозный аборт. Руководство для врачей / под ред. В.Е. Радзинского. Москва : МЕДпресс-информ, 2015.

[9]

Sinchikhin SP, Mamiev OB. Evaluation of the effectiveness of the algorithm for medical termination of pregnancy and post-abortion rehabilitation. Gynecology. 2008;10(1):56–60. (In Russ).

[10]

Синчихин С.П., Мамиев О.Б. Оценка эффективности алгоритма медикаментозного прерывания беременности и постабортной реабилитации // Гинекология. 2008. Т. 10, № 1. С. 56–60.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

157

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/